Prevention of death from endotoxin with antisera. I. The risk of fatal anaphylaxis to endotoxin - PubMed (original) (raw)
. 1969 Mar;102(3):563-72.
- PMID: 4180046
Prevention of death from endotoxin with antisera. I. The risk of fatal anaphylaxis to endotoxin
C E Davis et al. J Immunol. 1969 Mar.
No abstract available
Similar articles
- J5 prevents endotoxin shock in suckling rats.
Yoshioka T, Goto M, Kodama M, Gottschalk ME, Anderson CL, Young MR, Zeller WP. Yoshioka T, et al. Res Commun Chem Pathol Pharmacol. 1993 Jun;80(3):367-70. Res Commun Chem Pathol Pharmacol. 1993. PMID: 8351416 - Human antiserum for prevention of the local shwartzman reaction and death from bacterial lipopolysaccharides.
Ziegler EJ, Douglas H, Braude AI. Ziegler EJ, et al. J Clin Invest. 1973 Dec;52(12):3236-8. doi: 10.1172/JCI107524. J Clin Invest. 1973. PMID: 4584346 Free PMC article. - Protection against lethality of E. coli endotoxin with "O" antiserum.
Tate WJ 3rd, Douglas H, Braude AI, Wells WW. Tate WJ 3rd, et al. Ann N Y Acad Sci. 1966 Jun 30;133(2):746-62. doi: 10.1111/j.1749-6632.1966.tb52403.x. Ann N Y Acad Sci. 1966. PMID: 4164249 No abstract available. - [Significance of E. coli endotoxin in the pathogenesis of burn toxemia].
Fedorov NA, Golosova TV, Nedoshivina RV, Murashova NS. Fedorov NA, et al. Eksp Khir Anesteziol. 1974 Jul-Aug;0(4):41-4. Eksp Khir Anesteziol. 1974. PMID: 4605944 Russian. No abstract available. - Use of immunoadsorption techniques in the preparation of chemical agammaglobulinemia.
Frommel D, Dupuy JM, Litman GW, Good RA. Frommel D, et al. J Immunol. 1970 Nov;105(5):1292-3. J Immunol. 1970. PMID: 4099054 No abstract available.
Cited by
- Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review.
Zhu CS, Wang W, Qiang X, Chen W, Lan X, Li J, Wang H. Zhu CS, et al. Cells. 2021 Aug 27;10(9):2220. doi: 10.3390/cells10092220. Cells. 2021. PMID: 34571869 Free PMC article. Review. - Sepsis: Inflammation Is a Necessary Evil.
Nedeva C, Menassa J, Puthalakath H. Nedeva C, et al. Front Cell Dev Biol. 2019 Jun 20;7:108. doi: 10.3389/fcell.2019.00108. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31281814 Free PMC article. Review. - Strategies to improve drug development for sepsis.
Fink MP, Warren HS. Fink MP, et al. Nat Rev Drug Discov. 2014 Oct;13(10):741-58. doi: 10.1038/nrd4368. Epub 2014 Sep 5. Nat Rev Drug Discov. 2014. PMID: 25190187 Review. - Sepsis induced by cecal ligation and puncture.
Wen H. Wen H. Methods Mol Biol. 2013;1031:117-24. doi: 10.1007/978-1-62703-481-4_15. Methods Mol Biol. 2013. PMID: 23824895 Free PMC article. - Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.
Wang H, Ward MF, Sama AE. Wang H, et al. Shock. 2009 Oct;32(4):348-57. doi: 10.1097/SHK.0b013e3181a551bd. Shock. 2009. PMID: 19333143 Free PMC article. Review.